Towards Healthcare
Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market
Updated Date: 13 February 2026   |   Report Code: 6676

Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market Size and Companies (2026-2035)

Based on our estimations, the extracorporeal membrane oxygenation (ECMO) outsourcing service market was valued at USD 1.48 billion in 2025 and is projected to grow from USD 1.62 billion in 2026 to USD 3.58 billion by 2035, expanding at a CAGR of 9.24% (2026–2035).

Last Updated : 13 February 2026 Category: Healthcare Services Insight Code: 6676 Format: PDF / PPT / Excel
Revenue, 2025
USD 1.48 Billion
Forecast, 2035
USD 3.58 Billion
CAGR, 2026-2035
9.24%
Report Coverage
Global

The global extracorporeal membrane oxygenation (ECMO) outsourcing service market size was estimated at USD 1.48 billion in 2025 and is predicted to increase from USD 1.62 billion in 2026 to approximately USD 3.58 billion by 2035, expanding at a CAGR of 9.24% from 2026 to 2035.

Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market Trends and Growth (2026)

The growing cardiac and respiratory diseases are increasing the demand for ECMO outsourcing services, where the increasing integration of AI and new ECMO platform launches are also enhancing the market growth.

Key Takeaways

  • The extracorporeal membrane oxygenation (ECMO) outsourcing service market will likely exceed USD 1.62 billion by 2026.
  • Valuation is projected to hit USD 3.58 billion by 2035.
  • Estimated to grow at a CAGR of 9.24% starting from 2026 to 2035.
  • North America held the major revenue share of approximate 41% in the global extracorporeal membrane oxygenation (ECMO) outsourcing service market in 2025.
  • Asia Pacific is expected to be the fastest-growing region between 2026 and 2035.
  • By service type, the clinical management segment held an approximate 58% share in the market in 2025.
  • By service type, the training & education segment is expected to be the fastest growing during the forecast period.
  • By application type, the cardiac support segment held approximately 52% share in the market in 2025.
  • By application type, the ECPR (resuscitation) segment is expected to be the fastest-growing during the forecast period.
  • By patient type, the adult segment held an approximate 62% share in the market in 2025.
  • By patient type, the pediatric segment is expected to be the fastest growing during the forecast period.
  • By end user, the tertiary care hospitals segment held approximately 70% share in the market in 2025.
  • By end user, the ASCs segment is expected to be the fastest growing during the forecast period.

What is Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service?

The extracorporeal membrane oxygenation (ECMO) outsourcing service market is driven by a growing shortage of specialized perfusionists and the high capital cost of equipment. The extracorporeal membrane oxygenation (ECMO) outsourcing service encompasses third-party specialized firms providing clinical management, equipment maintenance, and technical staffing for ECMO. This allows healthcare facilities to offer life-saving cardiac and respiratory support without the high capital investment and intensive training required to manage complex ECMO programs in-house.

Why is the Use of AI Increasing in the Market?

The use of AI in the extracorporeal membrane oxygenation (ECMO) outsourcing service market is increasing, as it analyzes real-time ECMO data and predicts disease complications, offering early alerts. It also optimizes various ECMO parameters, enhancing its operational efficiency. At the same time, AI also helps outsourced ECMO systems in remote patient monitoring, integration with ICU platforms, and training.

Flourishing Flexible ECMO Models

The outsourcing providers are developing various tele-ECMO models and mobile ECMO support teams, which are increasing their acceptance rates for remote specialist consultations and emergency conditions.

Expanding Applications

The applications of the ECMO outsourcing services are increasing, which is driving their demand for training, data management, simulation programs, and quality assurance services to enhance patient outcomes and support the hospital personnel.

Technological advancements

There is a rise in the use of digital health tools and remote monitoring solutions in the outsourcing services, which is enabling the real-time monitoring and optimization of clinical decisions, improving the efficiency of the ECMO systems.

Executive Summary Table

Key Elements Scope
Market Size in 2026 USD 1.62 Billion
Projected Market Size in 2035 USD 3.58 Billion
CAGR (2026 - 2035) 9.24%
Leading Region North America by 41%
Market Segmentation By Service Type, By Application, By Patient Type, By End-User, By Region
Top Key Players Getinge AB (Maquet), Medtronic plc, Fresenius Medical Care (Xenios AG), LivaNova PLC, Terumo Corporation, Abbott Laboratories, Nipro Corporation, MicroPort Scientific Corporation, OriGen Biomedical, Inc.

Segmental Insights

By Service Type Insights

Why Did the Clinical Management Segment Dominate in the Market in 2025?

The clinical management segment held the largest share of approximate 58% in the extracorporeal membrane oxygenation (ECMO) outsourcing service market in 2025, due to its enhanced patient care. They also offered ECMO expertise, which increased patient adherence and outcomes.

Training & Education

The training & education segment is expected to show the highest growth during the upcoming years, due to growing innovations. Their complex procedures and increasing adoption rates are also increasing their demand for training and education. Additionally, increasing online platforms are also enhancing their use.

By Application Insights

How Cardiac Support Segment Dominated the Market in 2025?

The cardiac support segment led the extracorporeal membrane oxygenation (ECMO) outsourcing service market with an approximate 52% share in 2025, due to growth in cardiac diseases. This increased the demand for ECMO outsourcing services, where the growth in surgeries also increased their use.

ECPR (Resuscitation)

The ECPR (resuscitation) segment is expected to show the fastest growth rate during the upcoming years, due to its enhanced survival rates. Additionally, the increasing development of portable ECMO systems is also increasing their use in emergency conditions, enhancing patient outcomes.

By Patient Type Insights

Which Patient Type Segment Held the Dominating Share of the Market in 2025?

The adult segment held the dominating share of approximate 62% in the extracorporeal membrane oxygenation (ECMO) outsourcing service market in 2025, due to growth in chronic diseases. Moreover, the rise in surgeries and transplantations also increased the demand for ECMO outsourcing services.

Pediatric

The pediatric segment is expected to show the highest growth during the predicted time, due to rising congenital heart defects. The growing health awareness and expanding paediatric care units are also increasing the use of ECMO outsourcing services. Furthermore, the growing technological innovations are also enhancing their adoption rates.

By End-User Insights

What Made Tertiary Care Hospitals the Dominant Segment in the Market in 2025?

The tertiary care hospitals segment led the extracorporeal membrane oxygenation (ECMO) outsourcing service market with an approximate 70% share in 2025, due to the growth in the patient volume. Additionally, 24/7 care and advanced infrastructure also increased their demand.

ASCs 

The ASCs segment is expected to show the fastest growth rate during the predicted time, due to growing outpatient services. Moreover, the presence of affordable services and advanced technologies is also attracting patients. Additionally, their streamlined care and expanding network are also increasing their use.

Regional Insights

Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market Share, By Region, 2025 (%)

Advanced Infrastructure Drives North America

North America dominated the extracorporeal membrane oxygenation (ECMO) outsourcing service market with approximate 41% in 2025, due to the presence of advanced critical care infrastructure. The growth in the early adoption of outsourcing models to mitigate hospital staffing shortages and increased healthcare investments also contributed to the market growth.

U.S. Market Trends

The U.S. consists of advanced healthcare systems, which are increasing the adoption of various ECMO systems, driving the demand for ECMO outsourcing services. The growing telemedicine platforms are also increasing their use for real-time patient monitoring, decision support, and predictive alerts, which are leading to new collaborations.

Expanding Healthcare Boost Asia Pacific

Asia Pacific is expected to host the fastest-growing extracorporeal membrane oxygenation (ECMO) outsourcing service market during the forecast period, due to expanding healthcare. The increasing prevalence of cardiovascular diseases, technological innovations, and shortage of skilled ECMO personnel are also increasing their adoption rates, enhancing the market growth.

China Market Trends

China is experiencing rapid hospital modernization, which is increasing the use of ECMO outsourcing services. Additionally, the growing disease burden and lack of trained ECMO specialists are also increasing the demand. The growing government initiatives and technological advancements are also encouraging their use.

Europe Driven by Growing Awareness

Europe is expected to grow significantly in the extracorporeal membrane oxygenation (ECMO) outsourcing service market during the forecast period, due to growing clinical awareness. The presence of advanced healthcare infrastructure, an increasingly skilled workforce, and growing government support are also increasing the adoption of the ECMO outsourcing service, promoting market growth.

UK Market Trends

The presence of a well-developed healthcare system in the UK is increasing the use of ECMO outsourcing services to support the hospital staff and offer remote care, to tackle the increasing cardiovascular and respiratory diseases. Moreover, their demand is also increasing to overcome the shortage of skilled personnel by promoting their training programs.

Estimated Cardiovascular Disease Incidences in UK

Market Value Chain Analysis

R&D

  • The R&D of the extracorporeal membrane oxygenation (ECMO) outsourcing service focuses on the development of mobile retrieval technologies and AI-driven remote patient monitoring.
  • Key players: SpecialtyCare, Getinge, LivaNova.

Clinical Trials and Regulatory Approvals

  • Patient safety outcomes, efficacy of mobile transport protocols, and perfusionist competency standards are evaluated in the clinical trials and regulatory approvals of the extracorporeal membrane oxygenation (ECMO) outsourcing services.
  • Key players: SpecialtyCare, Innovative ECMO Concepts Inc.

Patient Support and Services

  • 24/7 bedside clinical management, comprehensive family education, and long-distance mobile retrieval are provided in the patient support and services of the extracorporeal membrane oxygenation (ECMO) outsourcing service.
  • Key players: SpecialtyCare, Innovative ECMO Concepts Inc.

Who are the Market Top Vendors and What are Their Offerings?

Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market Key Players

Companies Headquarters Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service
Getinge AB (Maquet) Gothenburg, Sweden Modular equipment solutions, clinical education, and maintenance
Medtronic plc Dublin, Ireland Clinical education and technical training
Fresenius Medical Care (Xenios AG) Bad Homburg, Germany Extensive training and on-site clinical application support for Novalung and Medos ECMO platforms
LivaNova PLC London, UK Turnkey ECMO systems
Terumo Corporation Tokyo, Japan Clinical specialists and perfusionists led training and equipment implementation.
Abbott Laboratories Illinois, U.S. CentriMag acute circulatory support system
Nipro Corporation Osaka, Japan Oxygenators and tubing sets
MicroPort Scientific Corporation Shanghai, China Technical servicing and clinical training for Vitaspring
Eurosets S.r.l. Medolla, Italy ECMOLife system
OriGen Biomedical, Inc.  Texas, U.S. Manufacture specialized ECMO and cannulae accessories.

SWOT Analysis

Strengths

  • The extracorporeal membrane oxygenation (ECMO) outsourcing service offers specialized expertise, which is increasing its use.
  • Their compliance with the standardized protocols helps in reducing complications and enhancing survival rates.
  • They also offer 24/7 availability and continuous patient care, which increases their acceptance rates.
  • Moreover, their affordable services also lead to new collaborations.

Weaknesses

  • High cost acts as the major weakness in the extracorporeal membrane oxygenation (ECMO) outsourcing service market, limiting its use.
  • The dependence on external providers also reduces their use due to the risk of a lack of their services during emergency conditions.

Opportunities

  • The growing incidences of cardiac and respiratory disease are increasing the demand for ECMO solutions, driving their outsourcing trends.
  • The growing clinical awareness and neonatal and periaditric clinics are also increasing the adoption of these services.
  • The growing procedural complexities are also increasing their demand for maintenance, repairs, and data management services.
  • The growing shift towards remote healthcare is also increasing its use for various purposes.

Threats

  • The ECO system requires sophisticated components, where their limited availability slows down the development process.
  • The stringent regulations and technological obsolescence also reduce their innovations.

What are the Recent Developments in the Market?

  • In August 2025, the launch of a platform company with an aim to unify specialized ECMO, Normothermic Regional Perfusion (NRP), and perfusion services for hospitals, organ procurement organizations, and health systems nationwide was announced by Integration Health.
  • In September 2024, a new configurable one-system ECMO solution called VitalFlow™ was launched by Medtronic plc to overcome the gap between bedside care and intra-hospital transport.

Segments Covered in the Report

By Service Type

  • Clinical Management
  • Training & Education
  • Maintenance & Repair 
  • Consulting & Others 

By Application

  • Cardiac Support
  • Respiratory Support
  • ECPR (Resuscitation)

By Patient Type

  • Adult
  • Pediatric
  • Neonates

By End-User

  • Tertiary Care Hospitals
  • Specialty Clinics
  • ASCs

By Region 

  • North America
    • U.S.
    • Canada 
    • Mexico 
    • Rest of North America
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe 
    • Western Europe 
      • Germany 
      • Italy
      • France
      • Netherlands
      • Spain
      • Portugal 
      • Belgium
      • Ireland
      • UK 
      • Iceland 
      • Switzerland
      • Poland
      • Rest of Western Europe
    • Eastern Europe 
      • Austria
      • Russia & Belarus 
      • Türkiye
      • Albania 
      • Rest of Eastern Europe 
  • Asia Pacific
    • China 
    • Taiwan
    • India 
    • Japan 
    • Australia and New Zealand
    • ASEAN Countries (Singapore, Malaysia)
    • South Korea 
    • Rest of APAC 
  • MEA 
    • GCC Countries
      • Saudi Arabia 
      • United Arab Emirates (UAE)
      • Qatar 
      • Kuwait 
      • Oman 
      • Bahrain 
    • South Africa
    • Egypt 
    • Rest of MEA

FAQ's

Finding : The extracorporeal membrane oxygenation (ECMO) outsourcing service market is expected to grow from USD 1.62 billion in 2026 to USD 3.58 billion by 2035, expanding at a CAGR of 9.24%.

Finding : North America is currently leading the extracorporeal membrane oxygenation (ECMO) outsourcing service market by 41% due to the presence of advanced critical care infrastructure.

Finding : British Heart Foundation, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

Tags

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar

Related Reports